In patients meeting the EFNS/PNS criteria for definite CIDP, the frequency of antibodies to Caspr1 and CNTN1 complex was 1.9% in a Barcelona, Spain, cohort and 4.3% in a German cohort of acute-onset CIDP. The gene discussed is CNTNAP1; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.